Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Stomatitis 1

Interventions

Cisplatin 6Radiotherapy, Intensity-Modulated 4Saline Solution 3Injections 3golotimod 2avasopasem manganese 2Water 2Vitamin B 12 2Standard of Care 2RRx-001 2Practice Guidelines as Topic 2Gentamicins 2Fibroblast Growth Factor 7 2FGF20 protein, human 2Drug Therapy 2samital 1regramostim 1peppermint oil 1meclocycline 1hydrated silica gel-based toothpaste 1holy basil leaf extract 1cobiprostone 1clazakizumab 1calcium phosphate 1brilacidin 1anise oil 1amlexanox 1aluminum hydroxide, magnesium hydroxide, drug combination 1Xylitol 1Vincristine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Stomatitis × cobiprostone × Clear all
NCT02542215 2019-12-02

Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and Chemotherapy

Mallinckrodt

Phase 2 Terminated
47 enrolled

Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡